James Brugarolas | sciencenewsnet.in

Breaking News

New Imaging Technique Reveals Detailed Map of Brain’s Blood Flow in 3D

RUSH Earns Innovation Award for Caregiver Support

Hackensack Meridian Pascack Valley Medical Center Earns An ‘A’ Hospital Safety Grade from The Leapfrog Group

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Hackensack Meridian Mountainside Medical Center Nurse Wins Research Award at ACC Quality Summit

Breakthrough Idea for CCU Technology Commercialization from ‘Carbon Cycle of the Earth’

Launch of nationwide map viewer and database aids wildfire planning and understanding of treatment effects

Scientists Gain New Insights into How Mass Is Distributed in Hadrons

MSU expert: What the history of lame-duck presidents can tell us about President Biden’s final actions

Helping Soldiers Serve on a Full Stomach

15 Nov, 2024

FDA Approval Of Belzutifan Culminates 25-Year Journey at UTSW From Gene Discovery to A First-In-Class Drug

August 23, 2021 sarah JonasResearch Results

DALLAS – Aug. 23, 2021 – A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.